Navigation Links
2 Tufts biomedical graduate students awarded HHMI research fellowships
Date:8/14/2013

BOSTON (August 14, 2013) The Howard Hughes Medical Institute has awarded two doctoral students from the Sackler School of Graduate Biomedical Sciences at Tufts University with 2013 International Student Research Fellowships. Seblewongel Asrat, from Ethiopia, studies the bacterium that causes Legionnaires' disease while Jennifer Nwankwo, from Nigeria, studies red blood cell dehydration in sickle cell disease. The HHMI fellowship program provides support for international pre-doctoral students who are conducting outstanding research in the biomedical and related sciences.

Asrat, a molecular microbiology student, seeks to understand how specific cells in the immune system inhibit replication of the bacterium that causes Legionnaires' disease, a severe form of pneumonia. She has identified a novel strategy that immune cells use to overcome pathogen attack. Her advisor is Ralph Isberg, Ph.D., Howard Hughes Medical Institute (HHMI) investigator and professor of molecular biology and microbiology at Tufts University School of Medicine (TUSM), and member of both the genetics and molecular microbiology program faculties at the Sackler School of Graduate Biomedical Sciences at Tufts. Asrat is in the MERGE-ID track (Medically-oriented Research in Graduate Education - Infectious Disease) program at the Sackler School. Her co-advisor in this program is Jennifer Chow, M.S., M.D., attending physician in infectious diseases at Tufts Medical Center as well as an assistant professor at TUSM.

Nwankwo studies sickle cell disease, a group of red blood cell disorders that include sickle cell anemia. She specifically studies the role of enzymes that cause red blood cell dehydration and cell adhesion critical events that lead to the painful crises that are the hallmark of sickle cell disease. Her goal is to identify enzymes that could be targeted by new drug treatments for the disorders. Nwankwo is a student in the Pharmacology & Experimental Therapeutics program at the Sackler School, advised by Athar Chishti, Ph.D., professor in the department of integrative physiology and pathobiology at TUSM and member of the cellular & molecular physiology; molecular microbiology; and pharmacology & experimental therapeutics program faculties at the Sackler School.

Asrat and Nwankwo are two of 42 international students selected to become 2013 HHMI International Student Research Fellows. Invited students must be in the third or fourth year of a Ph.D. program at a designated nominating institution.

"These highly-competitive fellowships support the training of students who are committed to high-quality research that advances science and human health. This honor reflects the excellence of their work and the dedication of our faculty to provide the best training possible for our students," said Naomi Rosenberg, Ph.D., dean of the Sackler School of Graduate Biomedical Sciences and vice dean for research at Tufts University School of Medicine.


'/>"/>

Contact: Siobhan Gallagher
617-636-6586
Tufts University, Health Sciences Campus
Source:Eurekalert

Related medicine news :

1. Tufts Medical Center researchers receive $10 million NIH grant to test blood clot prevention drug
2. Lifespan/Tufts/Brown Center for AIDS Research renewed with $8.5 million NIH grant
3. NYU Professor Li named Pew Scholar in Biomedical Sciences
4. California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014
5. General Data Acquires Triangle Biomedical Sciences
6. Mariner Biomedical Announces Results From an Independent Laboratory Confirming Deter Insect Repellent™ Effectively Repels Mosquitoes for 6 Hours
7. BIDMCs Mark Andermann, Ph.D., receives Smith Family Foundation Biomedical Research Award
8. ASU, Phoenix Childrens Hospital expand biomedical research partnership
9. Twelfth annual Wiley Prize in Biomedical Sciences awarded
10. An open platform revolutionizes biomedical-image processing
11. Human embryos frozen for 18 years yield viable stem cells suitable for biomedical research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2016)... ... April 30, 2016 , ... ... questioned the use of the HyProCure sinus tarsi implant. ( http://www.cbc.ca/news/canada/ottawa/banned-quebec-dentist-pierre-dupont-working-as-chiropodist-in-ottawa-1.3515494 ) ... is a minimally invasive procedure performed, when indicated, to correct the partial ...
(Date:4/29/2016)... ... ... In an article published April 16th on the New York ... injections, which she underwent in order to feel more at home at this year’s ... article explains that Ms. Mirmelli’s situation is not unique; many plastic surgeons say they’ve ...
(Date:4/29/2016)... ... April 29, 2016 , ... On Tuesday, April 26, ... the Southeast, celebrated the signature of Gov. Nathan Deal on SB 258, the “Rural ... (R - Cumming), offers a 70% tax credit to individuals and corporations which donate ...
(Date:4/29/2016)... ... , ... Coast Dental Fort Stewart is celebrating its grand opening with an ... Furniture Mall at 112 Vilseck Road in Fort Stewart. There will be refreshments, giveaways, ... have the opportunity to meet general dentists Thomas Richards, DDS, and Josh Faulk, DMD, ...
(Date:4/29/2016)... ... April 29, 2016 , ... World Patent ... Gyrociser, an exercise invention which aids in proper muscle development. , "The Gym ... and Creative Director of World Patent Marketing. "Globalization has threatened the future growth ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... JERUSALEM , April 28, 2016 ... ), a clinical-stage pharmaceutical company focused on the development of ... participate in the upcoming PIONEERS 2016 conference, presented by ... 5, 2016 in New York . ... overview at the conference. Presentation Details:   ...
(Date:4/28/2016)... TapImmune,Inc. (TPIV), a clinical-stage immune-oncology company ... and vaccines for the treatment of cancer & metastatic disease, ... Growth Capital Expo to be held on May 3 ... in Las Vegas, Nevada.  The Company presentation will be ... by Dr. John N. Bonfiglio a TapImmune Board ...
(Date:4/27/2016)... 2016 Im ... Zürich gab Strekin AG den Start einer ... Erhaltung des Resthörvermögens von Patienten, denen ein ... umfassende Phase-II-Doppelblindstudie mit Placebo-Kontrollgruppe werden momentan Patienten ... während der Operation direkt ins Mittelohr verabreicht. ...
Breaking Medicine Technology: